robsmark
Regular
It's amazing how all the trolls are coming out to play right now! He-he-he!
NAH-NEE-NAH-NEE-NAH-NAH!
Not gonna get our shares! Bum-bums!
Where are the trolls Bravo? I’ve read this page from top to bottom and can’t see any?
It's amazing how all the trolls are coming out to play right now! He-he-he!
NAH-NEE-NAH-NEE-NAH-NAH!
Not gonna get our shares! Bum-bums!
SPROGGO!!! As if that's not troll's name...Where are the trolls Bravo? I’ve read this page from top to bottom and can’t see any?
Have a look at his/her post history…SPROGGO!!! As if that's not troll's name...
Lol only 14 posts or so.How come you know Sproggo's history so well?
I clicked on his profile and lookedHow come you know Sproggo's history so well?
“When somebody takes a license from us most likely it is way at the front end design cycle and so at best, at best they’re 2 to 3 years out from having production in any sort of meaningful volume, so to be honest they might not even get there so given the time frames plus all the other features that they have to work on that they haven’t done yet at the time they’ve taken a license from us you know our licensee might want to wait a bit before tipping the market with respect to to what technology they’re working on or what product they’ll be producing and naturally this impacts how we make announcements to the market place.”As I’ve been saying for a long time now that just because there isn’t a license agreement announced does not mean that customers aren’t designing proof of concepts and getting to production with akida, because the customers simply do not want it to be announced due to NDA’s and other confidentiality reasons but people just want sugar hits and not want to wait for the fruit to bear.
Antonio said-
“Every commercial situation is different you know and plus there are confidentiality issues with our partners that we have to be mindful of as well, we can’t forward announce anything that they’re doing, allow me to stress that a little bit more.
When somebody takes a license from us most likely it is way at the front end design cycle and so at best, at best they’re 2 to 3 years out from having production in any sort of meaningful volume, so to be honest they might not even get there so given the time frames plus all the other features that they have to work on that they haven’t done yet at the time they’ve taken a license from us you know our licensee might want to wait a bit before tipping the market with respect to to what technology they’re working on or what product they’ll be producing and naturally this impacts how we make announcements to the market place.
You know for example have you heard of anyone in the world saying that they’re designed into the Galaxy s26 or the iPhone 16? I mean you haven’t heard that it’s too early.
Now I’m pretty confident I don’t think I’m saying anything wrong by saying I’m sure a lot of decisions with respect to those products have already been made but there’s no announcements because they’re not tipping the market yet so there’s a lot of nuances and variances”
I am trying to reconcile the many good and considered posts positing that Akida IP may be in Valeos SCALA 3 or some of the 2024 Mercedes models (out later this year) with the understandably limited information from our company regarding commercially sensitive business dealings and indeed license agreements.
Unless valeo or Mercedes have taken one of the two licenses through megachips or are relying on the 2 node renesas licence then I cannot help but think it highly unlikely that these companies would announce upcoming products to the market, take orders for those products and move to produce those products without the contractual wherewithal in place to guarantee the terms of the relationship with all suppliers.
It may well be that the original EAP agreements or for instance the terms of the partnership agreement with Valeo ( some of which were announced at the time of the partnership announcement) were adequate to cover all future eventualities but I think this seems unlikely. I know that Dio has suggested that with respect to valeo this may well be the case (and I do regard his posts/views highly) but I must admit I am less confident. The reference to milestone payments and the like is certainly reassuring but this seems more aligned to the product development phase than the production phase. It doesn’t mean of course that the agreement doesn’t contain licence fee or production terms clauses but there is not as far as I can see any reference to them.
My understanding of the relevant ASX listing requirements is that certain commercially sensitive licence agreements need not be announced to the market and this may provide an out for our company. however, we would in this case still expect an upfront revenue kicker to show up in the accounts which I do not believe it has done as yet.
Whilst it appears highly highly likely that our working relationship with valeo and merc continue I am hoping that our inclusion in their future products is imminent and not too many iterations away.
I look forward to anyone’s thoughts that may help me to achieve some clarity on this issue.
Cheers.
Well.. for all we know, they might as well wait for Akido 3.0 ir Akido 69 at this rate...Yes, the 1H23 report reflects a lacklustre 6 months for the company from a sales perspective.
How some shareholders on here were expecting anything different though is beyond me. What company in their right mind was going to sign an IP licence with Brainchip in the first half of 2023 when Akida 2.0 benefits are right around the corner? As Sean noted in the AGM, the second generation of Akida with its incredible improvements and additional functionality, was developed as a result of direct feedback from customers as to their requirements.
Considering lead adopters have been engaged with the benefits of Akida 2.0 for a short while now with general availability supposedly available now as per @Fact Finder recent post, we should surely be expecting some sales conversions. My personal timeframe to start seeing some more numbers on the boards (IP licences) is 6-12 months. We've been patient. Leeway has been given for much longer than anticipated but with the release of the 2.0 platform, there are no more excuses to deliver tangible, financial results.